S-CELLERATE
LIVE

Serial Number

79339661

Owner

Samsung Biologics Co., Ltd.

Attorney

Lisa C. Pavento

Filing Date

Jan 25, 2022

Add to watchlist:

No watchlists yet
View on USPTO

S-CELLERATE Trademark

Serial Number: 79339661 • Registration: 7490485

S-CELLERATE is a trademark filed by Samsung Biologics Co., Ltd. on January 25, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Samsung Biologics Co., Ltd. (26 trademarks)

300, Songdo bio-daero,

Entity Type: 03

Trademark Details

Filing Date

January 25, 2022

Registration Date

September 3, 2024

Published for Opposition

June 18, 2024

Goods & Services

Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials; custom manufacture of biopharmaceutical materials with generation of cell line; chemical treatment of liquids; processing of medicinal materials; custom manufacture of pharmaceuticals; processing of pharmaceutical preparations; preservation of pharmaceuticals; processing of medical products; processing of chemicals

Medical research in the field of crude drugs; development of cell therapy products; development of pharmaceutical preparations and medicines; drug development; inspection of pharmaceuticals; research of pharmaceuticals; clinical testing of medicines; pharmaceutical products evaluation; research of medical products; bacteriological research and analysis; medical laboratory services; stem cell research services; scientific research in the nature of conducting clinical trials; medicine research; research and development of technology for biotechnology; microbial testing for scientific research purposes; biochemistry research services; scientific research in the field of genetics; scientific research in the field of genetic engineering

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 8, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 16, 2025 FICS
FINAL DISPOSITION PROCESSED
Feb 16, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 3, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 3, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 3, 2024 R.PR
NOTIFICATION PROCESSED BY IB
Jul 1, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 18, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 18, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 11, 2024 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 11, 2024 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 29, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 16, 2024 CNSA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 1, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 13, 2023 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 13, 2023 OPNR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 21, 2023 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 23, 2023 RFCS
REFUSAL PROCESSED BY MPU
Jan 23, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2022 RFCR
NON-FINAL ACTION WRITTEN
Nov 16, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2022 DOCK
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Oct 6, 2022 CORR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 10, 2022 CRCV
APPLICATION FILING RECEIPT MAILED
May 10, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 6, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 5, 2022 REPR